For example, several published researches suggested that KDELR2 can be a promotive factor for the tumorigenesis of glioblastoma (Liao et al., 2019; Mao et al., 2020) and breast cancer (Wei et al., 2021). The gene discussed is KDELR2; the disease is breast carcinoma.